MY ACCOUNT | NEWSLETTER |
 
 

Search

7 Results found


FDA Conditionally Approves Merck Animal Health's EXZOLT™ CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis)

Like0
Dislike0

FDA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from Merck Animal Health

Like0
Dislike0

FDA Approves Temporary Drug Importation

Like0
Dislike0

Chance's normal dog life: An update on his heart condition

Like0
Dislike0

AVMA webinar outlines FDA guidance on compounding drugs

Like0
Dislike0

FDA conditionally approves chemo-induced diarrhea treatment for dogs

Like0
Dislike0

FDA approved lymphoma therapy for canines

Like0
Dislike0
Page of 1        1  

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top